Compare AbbVie Inc (ABBV) vs Aegon Ltd. (AEG) Price & Performance

AbbVie IncTrade

Aegon Ltd.Trade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Aegon Ltd. — how do they compare? AbbVie Inc trades at $248.68 (market cap $438.19B), while Aegon Ltd. trades at $9.4 (market cap $14.16B). The key difference: AbbVie Inc is far larger — about 30.9× Aegon Ltd.'s market cap, and Aegon Ltd. pays the higher dividend (4.9%). Which is the better fit depends on your goals.

	ABBV	AEG
Market Cap	$438.19B	$14.16B
Sector	Health	Financials
52-Week High	$263.58	$9.53
52-Week Low	$197.38	$6.79
Enterprise Value	$502.45B	$15.31B
Dividend Yield	2.79%	4.9%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.

Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.

Aegon Ltd.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 20 hours agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 1 day agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

AEG

View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Aegon Ltd.

Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.